• Sunho Biologics held an extraordinary general meeting on Aug. 27, 2026.
• Shareholders rejected a resolution to appoint Dr. XIA Long as a non-executive director, effective immediately upon passage.
• No board change was implemented because the resolution did not pass.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunho Biologics Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12302839), on August 27, 2026, and is solely responsible for the information contained therein.